(Q31106562)

28 June 2017

A quick diversity-oriented amide-forming reaction to optimize P-subsite residues of HIV protease inhibitors (English)

1 reference

28 June 2017

4

Chi-Huey Wong

1 reference

28 June 2017

Ashraf Brik

1

1 reference

PubMed ID

12204688

28 June 2017

Ying-Chuan Lin

series ordinal

2

1 reference

PubMed ID

12204688

28 June 2017

John Elder

series ordinal

3

1 reference

28 June 2017

1 August 2002

1 reference

28 June 2017

Chemistry and Biology

1 reference

28 June 2017

9

1 reference

28 June 2017

891-896

1 reference

28 June 2017

8

1 reference

Discovery and clinical development of HIV-1 protease inhibitors

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900184-9

7 January 2021

Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900184-9

7 January 2021

Structure-based inhibitors of HIV-1 protease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900184-9

7 January 2021

Structural mechanisms of HIV drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900184-9

7 January 2021

A potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TMC-126), and selection of a novel (A28S) mutation in the protease active site

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900184-9

7 January 2021

Combinatorial diversification of indinavir: in vivo mixture dosing of an HIV protease inhibitor library

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900184-9

7 January 2021

Expedient method for the solid-phase synthesis of aspartic acid protease inhibitors directed toward the generation of libraries

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900184-9

7 January 2021

Synthetic chemical diversity: solid phase synthesis of libraries of C2 symmetric inhibitors of HIV protease containing diamino diol and diamino alcohol cores

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900184-9

7 January 2021

Structure-activity studies of FIV and HIV protease inhibitors containing allophenylnorstatine

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900184-9

7 January 2021

Design, synthesis, and biological evaluation of HIV/FIV protease inhibitors incorporating a conformationally constrained macrocycle with a small P3' residue

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900184-9

7 January 2021

Development of a New Type of Protease Inhibitors, Efficacious against FIV and HIV Variants

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900184-9

7 January 2021

Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900184-9

7 January 2021

Syntheses of FDA Approved HIV Protease Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1074-5521%2802%2900184-9

7 January 2021

10.1016/S1074-5521(02)00184-9

Identifiers

DOI

1 reference

28 June 2017

1 reference

PubMed ID

12204688